Latest News
Biocon Limited
- BIOCON Outlook for the Week
- Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo
- Biocon clears path for cancer drug launch
- Biocon settles patent dispute with Genentech over breast cancer drug
- Biocon secures global settlement with Genentech for Pebrilzo launch
- Biocon settles Roche's US patent lawsuit over proposed breast-cancer drug copy
- Biocon inks patent settlement pact with Genentech for breast cancer drug
- Biocon secures earliest licensed launch dates for Pebrilzo® (bPertuzumab) following global patent settlement with Genentech
- Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates - CNBC TV18
- Upcoming IPO: Electrical products maker Biocon Electric files DRHP with SEBI
- Biocon Malaysia wins UK clearance as IOL Chemicals, NATCO Pharma advance Europe and capital plans
- Biocon Malaysia Receives UK Approval for Insulin Fill-Finish Unit
Headlines from the last 30 days, linking to the original publishers. See all market news →